3DMed nabs $140m co-led by China Securities unit, Efung Capital

3DMed nabs $140m co-led by China Securities unit, Efung Capital

09 October, 2020

3D Medicines Corporation China Capital Management Efung Capital

Printed by Unregistered user on Wed, 24 Dec 2025 11:53:18 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

Venture Capital

China Dealbook: TransLink leads $14m round in Uhouzz; 3D Medicines gets $101m funding

China Digest: 3D Med Diagnosis raises $40m; eRoad bags over $14m

Read more from Greater China

Global investors bet on Chinese AI as Wall Street fears bubble

Viewpoint: Hong Kong IPO market eyes continued recovery after comeback year 2025